Hepion Pharmaceuticals, Inc. - Common Stock (HEPA)

Last Price0.4100

Change+0.00 (0.00%)

NASDAQ · Last Trade: Apr 9th, 5:30 AM EDT

Hepion Pharmaceuticals (NASDAQ: HEPA) Reports Promising Phase 2 Trial Results for NASH Treatment

Renocofilstat's Positive Outcomes Reinforce Antifibrotic Action Hepion Pharmaceuticals, a clinical stage biopharmaceutical company focusing on AI-assisted therapeutic drug development, recently

Via Spotlight Growth · May 22, 2023